WebAug 11, 2024 · BOSTON – August 11, 2024 – Pear Therapeutics, Inc.(Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today reported results for … WebBOSTON & SAN FRANCISCO – June 22, 2024 – Pear Therapeutics, Inc. (“Pear”), the leader in developing and commercializing prescription digital therapeutics (PDTs) to treat serious …
Pear Therapeutics Reports Third Quarter 2024 Results
WebBoston 200 State Street Boston, MA 02109 San Francisco 201 Mission Street San Francisco, CA 94105 WebPear Therapeutics Investment Highlights Transformational opportunity to disrupt the >$3T global healthcare industry with software-based therapeutics that can address unmet 1 … eddie bauer fly fishing sheets
9 reasons why the Pear Therapeutics bankruptcy doesn’t
WebSep 30, 2024 · Third quarter revenue grew to $4.1 million, up from $3.3 million in Q2 2024, and compared with $1.3 million for the third quarter of 2024. *Definitions for Net Revenue, Total Prescriptions, Fulfillment Rate, Payment Rate, and ASP can be found in our Form 10-Q for the quarter ended September 30, 2024. WebJun 22, 2024 · Pear Therapeutics, which has three FDA-authorized apps to treat psychiatric disorders, plans to go public in a $1.6 billion special purpose acquisition corporation, or … WebEX-99.1 PEAR THERAPEUTICS INC INVESTOR PRESENTATION 11 JANUARY 2024 ex-991ptipresentation11j 1 Software-based Medicines for the Treatment of Serious Disease Prescription Digital Therapeutics Investor Presentation January 2024 Copyright 2024, Pear Therapeutics, Inc. All rights reserved. condo for sale in manchester nh